Patents Assigned to Kaohsiung Medical Univeristy
  • Patent number: 9775885
    Abstract: The present invention relates to a method for treating a bone loss disease, condition, or disorder in a subject in need thereof, comprising administering to said subject a pharmaceutically effective amount of a composition comprising thrombomodulin lectin-like domain (TMD1).
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: October 3, 2017
    Assignee: KAOHSIUNG MEDICAL UNIVERISTY
    Inventors: Tsung-Lin Cheng, Jwu-Lai Yeh, Mei-Ling Ho, Guey-Yueh Shi, Hua-Lin Wu
  • Publication number: 20100286163
    Abstract: Disclosed herein are indolo[3,2-c]quinoline compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein R and m are given the definitions as set forth in the Specification and Claims. These compounds can be used to inhibit both growth of cancer cells and activity of telomerase.
    Type: Application
    Filed: August 31, 2009
    Publication date: November 11, 2010
    Applicant: Kaohsiung Medical Univeristy
    Inventors: Cherng-Chyi Tzeng, Yeh-Long Chen, Jing-Jer Lin, Chih-Ming Lu